Evidence map›Paper›PMID 38533051›Full record

ReviewHeliyon2024

Therapeutic potential of clinically proven natural products in the management of dementia.

Farzana Ansari, Md Sohel, Md Mahfujul Haque Haidary, Md Saqline Mostaq, Shamima Akter, Asrafun Nahar, Fatematuz Zohora Labony, Arman Ahmed, Mohammed Shamim Hasan, Mohammad Hasem Babu and 1 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Farzana AnsariDepartment of Biochemistry and Molecular Biology, Laboratory of Nutrition and Health Research, University of Dhaka, Dhaka, 1000, Bangladesh.
Md SohelDepartment of Biochemistry and Molecular Biology, Mawlana Bhashani Science and Technology University, Santosh, Tangail, 1902, Bangladesh.
Md Mahfujul Haque HaidaryDepartment of Pharmacy, Primeasia University, Dhaka, 1213, Bangladesh.
Md Saqline MostaqDepartment of Pharmacy, University of Asia Pacific, Dhaka, 1205, Bangladesh.
Shamima AkterDepartment of Pharmacy, Atish Dipankar University of Science and Technology, Dhaka, 1230. Bangladesh.
Asrafun NaharDepartment of Pharmacy, Atish Dipankar University of Science and Technology, Dhaka, 1230. Bangladesh.
Fatematuz Zohora LabonyDepartment of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka, 1000, Bangladesh.
Arman AhmedDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Mohammed Shamim HasanDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Mohammad Hasem BabuDepartment of Pharmacy, Atish Dipankar University of Science and Technology, Dhaka, 1230. Bangladesh.
Mohammad Nurul AminPratyasha Health Biomedical Research Center, Dhaka, 1230, Bangladesh.
Atish Dipankar University of Science and Technology · BDNoakhali Science and Technology University · BDUniversity of Dhaka · BDMawlana Bhashani Science and Technology University · BDPrimeasia University · BDUniversity of Asia Pacific · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dementia is a common neurodegenerative disorder connected to damage to nerve cells in the brain. Although some conventional drugs are available for dementia treatments and are still sanctified for dementia patients, their short- and long-term side effects and other limitations make treating patients more challenging. The authors aimed to explain novel options for treating dementia with natural products and unravel some clinically proven natural products. This article systematically reviewed recent studies that have investigated the role of natural products and their bioactive compounds for dementia. PubMed Central, Scopus, and Google Scholar databases of articles were collected, and abstracts were reviewed for relevance to the subject matter.In this review, we provide mechanistic insights of clinically validated natural products, including like- Yokukansan, Souvenaid, BDW, Hupergene,

Indexed as

Bacopa monnierBDWDementiaHupergeneOmega-3PalmitoylethanolamideSouvenaidTramiprostateYokukansan

Identifiers

PMID38533051
PMCPMC10963206
OpenAlexW4392184788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.